ANGELA MEJIAS: Open Payments
NPI 1477573970 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$397 in 21 payments from 7 companies in 2025. Trend: 2023 $351 · 2024 $291 · 2025 $397
Food & beverage: $397
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $140 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $85 |
| Novo Nordisk Inc | 3 | $68 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $35 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $31 |
| ABBVIE INC. | 1 | $20 |
| Xeris Pharmaceuticals, Inc. | 1 | $18 |
Products named: AIRSUPRA, Kerendia, Rybelsus, JARDIANCE, CAPLYTA, FARXIGA, VRAYLAR, GVOKE HYPOPEN.
Industry payments across TN — which companies pay providers there.
